文献速递瓣膜病与结构性心脏病

英国新型TAVI术后30天死亡预后模型

Novel United Kingdom prognostic model for 30-day mortality following transcatheter aortic valve implantation.
PubMed 文献 · Heart · 2017-12-07

本研究利用2009-2014年英国TAVI注册数据(6339例,平均年龄81.3岁,女性46.2%)开发预测TAVI术后30天死亡的多变量逻辑回归模型,观察死亡率5.14%。最终模型含15个风险因素(包括2个衰弱变量),经乐观校正后校准良好(截距0.02,斜率0.79),AUC为0.66,显示中等区分度。

要点

  • 英国TAVI注册数据开发出含15个风险因素的30天死亡预测模型。
  • 模型校准良好(截距0.02,斜率0.79),区分度中等(AUC 0.66)。
  • 模型可用于基准比较,但需更广泛数据和探索其他结局。

核心结论

  • 英国TAVI预后模型在英国TAVI患者中显示强校准和中等区分度。
  • 该模型有基准比较潜力,但即使纳入衰弱变量仍需更广泛数据。

研究设计与样本

  • 两步建模策略:2009-2014年英国TAVI注册数据开发多变量逻辑回归模型,用2013-2014年数据更新模型。
  • 纳入34个中心共6339例患者,平均年龄81.3岁,女性2927例(46.2%)。
  • 通过Bootstrap内部验证估计样本内乐观校正性能。

主要发现

  • 观察到的30天死亡率为5.14%。
  • 最终模型包含15个风险因素,其中2个与衰弱相关。
  • 乐观校正后校准截距0.02(95%CI -0.17至0.20),校准斜率0.79(95%CI 0.55至1.03)。
  • 乐观校正后AUC为0.66。

临床怎么用

  • 模型可用于英国TAVI术后30天死亡风险的基准比较。
  • 临床使用时应考虑模型区分度中等,需结合其他临床信息。

局限性

  • 模型区分度中等(AUC 0.66)。
  • 即使纳入衰弱变量,仍需更广泛数据。
  • 其他结局未探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Existing clinical prediction models (CPM) for short-term mortality after transcatheter aortic valve implantation (TAVI) have limited applicability in the UK due to moderate predictive performance and inconsistent recording practices across registries. The aim of this study was to derive a UK-TAVI CPM to predict 30-day mortality risk for benchmarking purposes. METHODS: A two-step modelling strategy was undertaken: first, data from the UK-TAVI Registry between 2009 and 2014 were used to develop a multivariable logistic regression CPM using backwards stepwise regression. Second, model-updating techniques were applied using the 2013-2014 data, thereby leveraging new approaches to include frailty and to ensure the model was reflective of contemporary practice. Internal validation was performed by bootstrapping to estimate in-sample optimism-corrected performance. RESULTS: Between 2009 and 2014, up to 6339 patients were included across 34 centres in the UK-TAVI Registry (mean age, 81.3; 2927 female (46.2%)). The observed 30-day mortality rate was 5.14%. The final UK-TAVI CPM included 15 risk factors, which included two variables associated with frailty. After correction for in-sample optimism, the model was well calibrated, with a calibration intercept of 0.02 (95% CI -0.17 to 0.20) and calibration slope of 0.79 (95% CI 0.55 to 1.03). The area under the receiver operating characteristic curve, after adjustment for in-sample optimism, was 0.66. CONCLUSION: The UK-TAVI CPM demonstrated strong calibration and moderate discrimination in UK-TAVI patients. This model shows potential for benchmarking, but even the inclusion of frailty did not overcome the need for more wide-ranging data and other outcomes might usefully be explored.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Martin GP, Sperrin M, Ludman PF, et al. Novel United Kingdom prognostic model for 30-day mortality following transcatheter aortic valve implantation. Heart. 2017. PMID: 29217636. doi:10.1136/heartjnl-2017-312489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。